GENEVA, Aug. 21 -- EMORY UNIVERSITY filed a patent application (US2026/015295) for “USES OF HPA AXIS INHIBITORS AND INCRETIN TO PROMOTE WEIGHT LOSS”. With publication no. WO/2026/174215, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 3/04
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....